Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, if she will make an assessment of the adequacy of global funding for the (a) production and (b) distribution of the Mosquirix malaria vaccine in areas with high levels of malarial disease over the next 10 years.

The UK welcomes the World Health Organisation's recommendation for use of the new Mosquirix (RTS,S) malaria vaccine, alongside existing malaria tools such as bed nets, indoor sprays and chemoprevention, and recognises the need for sufficient global funding to ensure the benefits from this range of tools are maximised. The UK provides substantial core funding to Gavi, the Global Fund to Fight AIDS, TB and Malaria, and Unitaid who together committed $US 70 million to fund the RTS,S malaria vaccine pilots. We are supporting Gavi as a Board Member in their work on introducing the vaccine as part of national malaria control plans.